首页 > 最新文献

Annals of the Child Neurology Society最新文献

英文 中文
Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries 典型Rett综合征的症状发作:初始临床严重程度量表条目分析。
Pub Date : 2025-06-16 DOI: 10.1002/cns3.70017
Alan K. Percy, Jeffrey L. Neul, Amitha Ananth, Timothy A. Benke, Eric D. Marsh

Objective

We aim to assess the clinical features of Rett syndrome (RTT) at registration into the National Institutes of Health–sponsored natural history study (NHS) using the Clinical Severity Scale (CSS).

Introduction

The CSS was established in 2000 to assess characteristics of individuals with RTT and related disorders. We analyzed the CSS at enrollment into the NHS of all individuals with classic RTT.

Methods

The CSS of 1258 individuals was used to examine three historical items (age at regression, age at onset of hand stereotypies, and head growth) and 10 clinical features at initial enrollment.

Results

Among historical items, age at regression was most prominent after age 12 months with 8% regressing before this, hand stereotypies were most common after 18 months with 30% occurring before, and head growth was substantially lower overall. Hand use, ambulation, and communication skills were reduced in most individuals.

Discussion and Conclusion

These findings reflect core clinical criteria for classic RTT and mirror the top concerns registered independently by parents or caregivers. The CSS is an important analytic tool for the association of relative differences in clinical outcome with specific MECP2 variant groups and has been important in establishing entrance criteria in RTT clinical trials. The range of age-specific CSS features will continue to inform the RTT natural natural history as well as provide stratification and selection in future clinical trials, especially those involving younger participants.

目的:使用临床严重程度量表(CSS)评估Rett综合征(RTT)在美国国立卫生研究院(nih)赞助的自然历史(NH)研究中注册时的临床特征。CSS于2000年建立,用于评估RTT及相关疾病患者的特征。我们分析了所有经典RTT患者入组时的CSS。方法:采用1258个个体的CSS,对初始入组时的3个历史项目(回归年龄、手部刻板印象发生年龄和头部生长)和10个临床特征进行检验。结果:在历史项目中,年龄在12个月后回归最突出,在此之前回归8%,手刻板印象在18个月后最常见,在此之前发生30%,头部生长总体上明显较低。大多数患者的手部使用、行走和沟通能力都有所下降。讨论和结论:这些发现反映了经典RTT的核心临床标准,反映了父母或照顾者独立登记的最关心的问题。CSS是将临床结果的相对差异与特定MECP2变异组相关联的重要分析工具,在建立RTT临床试验的进入标准方面也很重要。年龄特异性CSS特征的范围将继续为RTT NH提供信息,并在未来的临床试验中提供分层和选择,特别是那些涉及年轻参与者的临床试验。
{"title":"Symptom Onset in Classic Rett Syndrome: Analysis of Initial Clinical Severity Scale Entries","authors":"Alan K. Percy,&nbsp;Jeffrey L. Neul,&nbsp;Amitha Ananth,&nbsp;Timothy A. Benke,&nbsp;Eric D. Marsh","doi":"10.1002/cns3.70017","DOIUrl":"10.1002/cns3.70017","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>We aim to assess the clinical features of Rett syndrome (RTT) at registration into the National Institutes of Health–sponsored natural history study (NHS) using the Clinical Severity Scale (CSS).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The CSS was established in 2000 to assess characteristics of individuals with RTT and related disorders. We analyzed the CSS at enrollment into the NHS of all individuals with classic RTT.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>The CSS of 1258 individuals was used to examine three historical items (age at regression, age at onset of hand stereotypies, and head growth) and 10 clinical features at initial enrollment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among historical items, age at regression was most prominent after age 12 months with 8% regressing before this, hand stereotypies were most common after 18 months with 30% occurring before, and head growth was substantially lower overall. Hand use, ambulation, and communication skills were reduced in most individuals.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Discussion and Conclusion</h3>\u0000 \u0000 <p>These findings reflect core clinical criteria for classic RTT and mirror the top concerns registered independently by parents or caregivers. The CSS is an important analytic tool for the association of relative differences in clinical outcome with specific <i>MECP2</i> variant groups and has been important in establishing entrance criteria in RTT clinical trials. The range of age-specific CSS features will continue to inform the RTT natural natural history as well as provide stratification and selection in future clinical trials, especially those involving younger participants.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 3","pages":"152-157"},"PeriodicalIF":0.0,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12380397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144980717","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Manganese Neurotoxicity and Familial Disorders of Manganese Transport 锰的神经毒性和锰转运的家族性疾病
Pub Date : 2025-06-12 DOI: 10.1002/cns3.70015
Sidney M. Gospe Jr.

Manganese is the 12th most common element in the Earth's crust and is an essential industrial component. Biologically, this metal plays an important role as a constituent of numerous enzymes. While manganese is required for normal biochemical and physiological processes, manganese excess can lead to significant toxicity, particularly to the central nervous system. Over the past 25 years, three inherited disorders of manganese transport have been described, leading to a model of how this essential metal is absorbed, distributed to tissues, and eliminated. The first part of this review describes the clinical features and cellular mechanisms of manganese toxicity due to occupational and environmental exposure. The remainder of the review discusses the familial disorder associated with hypomagnesemia, SLC39A8 deficiency, and the two genetic diseases resulting in hypermanganesemia, SLC30A10 deficiency and SLC39A14 deficiency. These latter two disorders are treatable, and the early recognition and institution of chelation therapy and iron supplementation can improve neurological disability. Ongoing research regarding the tissue-specific role of each transporter and their regulatory interplay, the varied mechanisms of manganese toxicity, and its treatment are also described.

锰是地壳中第12种最常见的元素,是一种重要的工业成分。在生物学上,这种金属作为许多酶的组成成分起着重要作用。虽然锰是正常生化和生理过程所必需的,但锰过量会导致严重的毒性,特别是对中枢神经系统。在过去的25年里,已经描述了三种锰运输的遗传性疾病,导致了这种必需金属如何被吸收、分布到组织和消除的模型。本综述的第一部分介绍了锰中毒的临床特点和细胞机制,由于职业和环境暴露。本综述的其余部分讨论了与低镁血症、SLC39A8缺乏症相关的家族性疾病,以及导致高镁血症、SLC30A10缺乏症和SLC39A14缺乏症的两种遗传性疾病。后两种疾病是可以治疗的,早期发现并采用螯合治疗和补铁可以改善神经功能障碍。正在进行的研究关于每个转运体的组织特异性作用和它们的调节相互作用,锰毒性的各种机制,及其治疗也进行了描述。
{"title":"Manganese Neurotoxicity and Familial Disorders of Manganese Transport","authors":"Sidney M. Gospe Jr.","doi":"10.1002/cns3.70015","DOIUrl":"https://doi.org/10.1002/cns3.70015","url":null,"abstract":"<p>Manganese is the 12th most common element in the Earth's crust and is an essential industrial component. Biologically, this metal plays an important role as a constituent of numerous enzymes. While manganese is required for normal biochemical and physiological processes, manganese excess can lead to significant toxicity, particularly to the central nervous system. Over the past 25 years, three inherited disorders of manganese transport have been described, leading to a model of how this essential metal is absorbed, distributed to tissues, and eliminated. The first part of this review describes the clinical features and cellular mechanisms of manganese toxicity due to occupational and environmental exposure. The remainder of the review discusses the familial disorder associated with hypomagnesemia, SLC39A8 deficiency, and the two genetic diseases resulting in hypermanganesemia, SLC30A10 deficiency and SLC39A14 deficiency. These latter two disorders are treatable, and the early recognition and institution of chelation therapy and iron supplementation can improve neurological disability. Ongoing research regarding the tissue-specific role of each transporter and their regulatory interplay, the varied mechanisms of manganese toxicity, and its treatment are also described.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 3","pages":"135-144"},"PeriodicalIF":0.0,"publicationDate":"2025-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70015","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145101039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epilepsy of Infancy With Migrating Focal Seizures 婴儿期癫痫伴局灶性迁移
Pub Date : 2025-06-10 DOI: 10.1002/cns3.70014
Samuel Kamoroff, Harry Abram, Fernando Galan

This 3-month-old boy had frequent recurrent events of right-arm stiffening and right head turn suggestive of focal seizures. Continuous electroencephalogram (EEG) showed subclinical focal seizures arising independently from the right occipital and left posterior head regions. These events persisted despite escalating use of lacosamide, levetiracetam, and phenobarbital. Given the patient's age, epilepsy of infancy with migrating focal seizures (EIMFS) was suspected. Early investigation with whole-exome sequencing revealed homozygous pathogenic variants in SLC12A5 (c.986C > A, p.Ala329Asp). Early recognition is vital in this epilepsy syndrome due to the difficulty in treating and subsequent prognosis. Given the expected drug resistance, early or urgent initiation of the ketogenic diet should be considered. The overall prognosis is not favorable, as poor developmental outcomes are expected.

EIMFS is a severe infantile-onset epilepsy syndrome characterized by refractory seizures, developmental delay, and migrating focal discharges [1]. SLC12A5 mutations have been identified as a cause of EIMFS, with nine patients reported to date, but KCNT1 remains responsible for about 50% of cases [2] (Figure 1). SLC12A5 encodes the potassium-chloride cotransporter KCC2, which is crucial for maintaining synaptic inhibition [3]. Mutations in SLC12A5 lead to decreased KCC2 surface expression, impaired chloride extrusion, and reduced protein glycosylation, resulting in neuronal hyperexcitability [3]. EIMFS typically presents before 6 months of age with focal motor seizures that become multifocal and intractable [2]. Treatment options are limited, but the ketogenic diet and potassium bromide have shown potential efficacy [2]. SLC12A5-related EIMFS is inherited in an autosomal recessive manner, with both de novo and inherited mutations reported [4].

Samuel Kamoroff: conceptualization, writing – original draft, writing – review and editing, data curation. Harry Abram: writing – review and editing, data curation, supervision. Fernando Galan: conceptualization, writing – review and editing, data curation, supervision.

The authors declare no conflicts of interest.

这个3个月大的男孩经常出现右臂僵硬和右头转动提示局灶性癫痫发作。连续脑电图(EEG)显示亚临床局灶性癫痫发作独立于右枕区和左后脑区。尽管拉科沙胺、左乙拉西坦和苯巴比妥的使用不断增加,这些事件仍然存在。考虑到患者的年龄,怀疑为婴儿期癫痫伴迁移局灶性发作(EIMFS)。早期全外显子组测序发现SLC12A5存在纯合子致病变异(c.986C >; A, p.Ala329Asp)。由于治疗和预后困难,早期识别对这种癫痫综合征至关重要。考虑到预期的耐药性,应考虑尽早或紧急开始生酮饮食。总体预后不佳,因为预期发育不良。EIMFS是一种严重的婴儿癫痫综合征,其特征是难治性癫痫发作、发育迟缓和移动性局灶性放电。SLC12A5突变已被确定为EIMFS的一个原因,迄今为止报告了9例患者,但KCNT1仍然负责约50%的bb0病例(图1)。SLC12A5编码氯化钾共转运蛋白KCC2,这对于维持突触抑制[3]至关重要。SLC12A5突变导致KCC2表面表达降低,氯离子挤压受损,蛋白糖基化减少,导致神经元高兴奋性[3]。EIMFS通常在6个月前表现为局灶性运动发作,并发展为多灶性难治性脑卒中。治疗选择有限,但生酮饮食和溴化钾已显示出潜在的疗效。slc12a5相关的EIMFS以常染色体隐性遗传方式遗传,新发和遗传突变均有报道。塞缪尔·卡莫罗夫:概念化,写作-原稿,写作-审查和编辑,数据管理。哈利亚伯兰:写作-审查和编辑,数据策展,监督。费尔南多·加兰:概念化,写作-审查和编辑,数据管理,监督。作者声明无利益冲突。
{"title":"Epilepsy of Infancy With Migrating Focal Seizures","authors":"Samuel Kamoroff,&nbsp;Harry Abram,&nbsp;Fernando Galan","doi":"10.1002/cns3.70014","DOIUrl":"https://doi.org/10.1002/cns3.70014","url":null,"abstract":"<p>This 3-month-old boy had frequent recurrent events of right-arm stiffening and right head turn suggestive of focal seizures. Continuous electroencephalogram (EEG) showed subclinical focal seizures arising independently from the right occipital and left posterior head regions. These events persisted despite escalating use of lacosamide, levetiracetam, and phenobarbital. Given the patient's age, epilepsy of infancy with migrating focal seizures (EIMFS) was suspected. Early investigation with whole-exome sequencing revealed homozygous pathogenic variants in <i>SLC12A5</i> (c.986C &gt; A, p.Ala329Asp). Early recognition is vital in this epilepsy syndrome due to the difficulty in treating and subsequent prognosis. Given the expected drug resistance, early or urgent initiation of the ketogenic diet should be considered. The overall prognosis is not favorable, as poor developmental outcomes are expected.</p><p>EIMFS is a severe infantile-onset epilepsy syndrome characterized by refractory seizures, developmental delay, and migrating focal discharges [<span>1</span>]. <i>SLC12A5</i> mutations have been identified as a cause of EIMFS, with nine patients reported to date, but <i>KCNT1</i> remains responsible for about 50% of cases [<span>2</span>] (Figure 1). <i>SLC12A5</i> encodes the potassium-chloride cotransporter KCC2, which is crucial for maintaining synaptic inhibition [<span>3</span>]. Mutations in <i>SLC12A5</i> lead to decreased KCC2 surface expression, impaired chloride extrusion, and reduced protein glycosylation, resulting in neuronal hyperexcitability [<span>3</span>]. EIMFS typically presents before 6 months of age with focal motor seizures that become multifocal and intractable [<span>2</span>]. Treatment options are limited, but the ketogenic diet and potassium bromide have shown potential efficacy [<span>2</span>]. <i>SLC12A5</i>-related EIMFS is inherited in an autosomal recessive manner, with both de novo and inherited mutations reported [<span>4</span>].</p><p><b>Samuel Kamoroff:</b> conceptualization, writing – original draft, writing – review and editing, data curation. <b>Harry Abram:</b> writing – review and editing, data curation, supervision. <b>Fernando Galan:</b> conceptualization, writing – review and editing, data curation, supervision.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"125-126"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70014","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Child Neurology Workforce Shortage: Challenges and Recommendations for Researching and Recruiting the Next Generation of Child Neurologists 儿童神经病学劳动力短缺:研究和招募下一代儿童神经学家的挑战和建议
Pub Date : 2025-06-10 DOI: 10.1002/cns3.70011
Sara A. Rubin, Peter E. Davis, Miya E. Bernson-Leung

For subspecialities like child neurology in which demand is predicted to increase and further exceed supply, understanding what attracts individuals to the field and deters individuals from it is particularly valuable. To explore this, we recently surveyed medical students and residents who had completed child neurology clerkships at US medical schools within the last approximately 7 years to investigate the antecedent factors that led to interest in these clerkships and the factors that subsequently impacted residency choice, child neurology or otherwise. Current child neurology and neurodevelopmental disabilities residents (postgraduate years [PGY] 1 through 5) and current medical students who completed at least one child neurology clerkship at a US medical institution were invited to complete an online survey through their residency program coordinators/directors or clerkship coordinators/directors. While our 38 respondents gave us useful insights, our difficulty reaching a larger sample of the population of interest (likely ~1000−5000 individuals) highlights several barriers to conducting workforce research. Here, we share relevant literature and our observations on the pipeline for careers in child neurology, current research challenges, and potential paths forward.

Early exposure to child neurology is critical for sparking interest in the field. Although studies have used different definitions of “early,” frequently referring to college and medical school [1], it is becoming more apparent that no exposure is too early for igniting interest. In our study, the most common timeframe for initial exposure to neurology was during college at 39%; however, exposure in high school or earlier was almost equally as common (37%). Popular media such as books by Oliver Sacks and fictional characters like Sherlock Holmes have been cited in residency personal statements as motivating interest in neurology [2]. These exposures along with chance encounters with neurologists through personal or family experience with neurological conditions, pediatric or otherwise, appear to be relevant when medical students are planning their career paths. It remains to be explored whether the specific exposure (pediatric, e.g., a sibling with autism, or adult, e.g., a grandparent with Alzheimer's disease) influences whether one decides to go into child neurology or adult neurology, especially given the lack of awareness among premedical and medical students that child neurology is its own specialty. Studying these types of “early” exposures could be fruitful for understanding how early lifeexperiences influence motivation to enter medicine and eventual specialty choice.

Undergraduate neuroscience courses are another crucial early exposure to the field. At present, there are inequities in access to such courses, which has implications for recruiting a diverse workforce [3]. In our survey, 24% of participants indicated tha

对于像儿童神经学这样的亚专业来说,需求预计会增加,并进一步超过供应,了解是什么吸引了人们进入这个领域,又是什么阻止了人们进入这个领域,是特别有价值的。为了探讨这一点,我们最近调查了在过去大约7年内在美国医学院完成儿童神经病学见习的医学生和住院医师,以调查导致对这些见习感兴趣的先决因素以及随后影响住院医师选择的因素,儿童神经病学或其他。目前的儿童神经病学和神经发育障碍住院医师(研究生阶段[PGY] 1 - 5)和目前在美国医疗机构完成至少一次儿童神经病学实习的医科学生被邀请通过他们的住院医师项目协调员/主任或实习协调员/主任完成一项在线调查。虽然我们的38名受访者为我们提供了有用的见解,但我们难以获得更大的感兴趣人群样本(可能为~1000 - 5000人),这突出了进行劳动力研究的几个障碍。在这里,我们分享了相关文献和我们对儿童神经病学职业发展、当前研究挑战和潜在发展路径的观察。早期接触儿童神经学对于激发对该领域的兴趣至关重要。尽管研究使用了不同的“早期”定义,通常指的是大学和医学院,但越来越明显的是,任何接触都不能太早点燃兴趣。在我们的研究中,首次接触神经学的最常见时间框架是在大学期间,占39%;然而,高中或更早接触大麻的情况几乎同样普遍(37%)。在住院医生的个人陈述中,奥利弗·萨克斯(Oliver Sacks)的书等流行媒体和夏洛克·福尔摩斯(Sherlock Holmes)等虚构人物都被引用为激发人们对神经学b[2]兴趣的原因。当医学生在规划他们的职业道路时,这些接触以及通过个人或家庭经历与神经系统疾病(儿科或其他)的神经科医生的偶然相遇似乎是相关的。具体的接触(儿童,例如,患有自闭症的兄弟姐妹,或成人,例如,患有阿尔茨海默病的祖父母)是否会影响一个人决定进入儿童神经病学或成人神经病学,这还有待探索,特别是考虑到医学预科学生和医科学生缺乏意识,儿童神经病学是自己的专业。研究这些类型的“早期”接触可能有助于理解早期生活经历如何影响进入医学领域的动机和最终的专业选择。本科生的神经科学课程是另一个重要的早期接触领域。目前,在获得此类课程方面存在不公平现象,这对招聘多样化的劳动力产生了影响。在我们的调查中,24%的参与者表示他们第一次接触神经科学/神经学是在医学院。因此,认识到医学院的神经科学临床前课程往往是接触该学科的第一门课程,强调了它们对招聘的重要性。除了最大限度地提高其可及性和吸引力之外,更多地纳入儿童神经病学主题,并仔细考虑教授这些课程的教师(即包括儿童神经病学教师、临床教师等),[4]将极大地促进曝光率和兴趣。神经学学生兴趣小组和儿科兴趣小组提供了在医学院期间接触的课外机会。这些组织依靠与神经病学/儿童神经病学部门的资助和伙伴关系来最大限度地发挥影响,这在各机构之间差别很大。我们发现COVID-19大流行与学生团体参与之间存在负相关关系,在未来几年支持这些团体将非常重要。临床接触和与儿童神经科医生的互动对于激发和维持对该领域的兴趣至关重要。即使是那些在临床预科课程后对神经病学或儿童神经病学不感兴趣的学生,有时也会在随后的临床经历和指导中发展出兴趣,包括在必要的经历中,如儿科或神经病学核心见习。我们发现,在我们的调查对象中,有较高比例的人在神经病学核心职员期间接触过儿童神经病学,这比之前的劳动力研究所预期的要高(75%对28%)。这种差异有许多可能的原因,但在必要的轮转期间,更多的儿童神经学接触机会可能会增加认识和兴趣。一旦个人确定了对儿童神经病学的兴趣,他们就必须决定是否将该专业作为职业。这通常是通过参加儿童神经病学和/或神经病学轮转/选修课来完成的。 我们发现,医学院的儿童神经学见习人员通常都很受欢迎;然而,有更多的门诊接触和指导的愿望。考虑到这些反馈,并为未来的儿童神经科医生创造机会与导师联系,并获得各种实践环境的机会,将提高对儿童神经科医生“生命中不同日子”的认识,并确保学生在选择职业时做出明智的决定。就像有机会和机会增加对儿童神经学的兴趣一样,该领域的某些方面可能会让未来的儿童神经学学员感到不快。这些方面不仅包括该学科特有的问题(例如,照顾患有严重神经疾病的儿童的困难),而且还包括目前的培训结构,因为它与经济前景、工作时间、长度和组成以及整体健康有关。儿童神经科医生面临着比成人神经科医生更低的薪水和终身收入潜力。此外,至少5年的培训要求意味着儿童神经科医生必须以较低的居民收入维持自己(可能还有他们的家庭)比许多其他专业更长。这可能支持数据表明,与成人神经学学员相比,儿童神经学学员接受额外奖学金培训的比例明显较低。鉴于那些来自医学背景的人往往背负着更大的教育债务,较长的培训时间和较低的长期收入潜力可能会进一步加剧儿童神经学多样性的缺乏。与2019 - 2023年美国医学院协会(AAMC)毕业问卷调查(GQ)中所有医学生的数据相比,我们确定,在我们的调查中,报告总债务≥10万美元的受访者较少(44%对所有GQ受访者的59% - 62%)。这表明,债务程度可能影响了儿童神经病学办事员的决定。在bbb领域的领导者中,一直在讨论缩短培训时间以及缩短12个月成人神经学培训和2年普通儿科培训的具体要求。在我们的调查中,一位受访者特别提到,要求完成2年的普通儿科培训是一种威慑。招聘的其他障碍包括生活方式因素,以及由于该领域的高度专业化而缺乏可用的导师。根据2015年劳动力调查的人口统计数据显示,79.9%的儿童神经科医生是白人,与其他儿科亚专科相比,导师之间缺乏多样性可能是来自代表性不足背景的个体从事儿童神经病学研究的另一个障碍[9,10]。考虑到导致个人追求(或不追求)儿童神经病学职业的不同时间框架和经历,决定谁,如何以及何时调查未来的儿童神经学家是困难的。医学院毕业前不久或毕业后是最接近专业决定的时间,因此是最佳的。理想情况下,研究应该包括那些考虑过儿童神经学的人,即使他们最终没有从事这方面的研究。由于研究儿童神经学的医学院毕业生相对较少,为了获得足够大的样本量以得出具有统计意义和实际意义的结论,此类研究必须跨越多个机构。目前进行这种多机构研究存在障碍,因为我们遇到了外部调查分布的限制,这些限制包括在个别机构以及通过美国神经病学学会的医学生和神经病学助理主任在线社区(目前在儿童神经病学学会没有类似的结构)。此外,与易于获得的儿童神经病学住院医师项目主任和管理员的联系信息相反,没有汇编的儿童神经病学医学教育者/见习主任的电子邮件列表,也没有直接在网上查找这些信息的方法。虽然有可能通过住院医师项目管理人员接触到最近的医学院毕业生,他们是儿童神经内科住院医师,但调查这一人群无法覆盖那些在某种程度上对儿童神经内科感兴趣但决定不从事儿童神经内科住院医师的医学生,这是一个了解职业决定的宝贵群体。此外,在从本科到研究生的医学教育过渡过程中,联系信息的丢失(即医学院的电子邮件地址)使得很难纵向跟踪个人。 越来越多的骨科和国际医学毕业生寻求美国儿童神经病学住院医师也使研究未来的儿童神经学家变得复杂,因为他们需要不同的外展。增加交流和合作的渠道,建立数据库,与AAMC和美国骨科医学院协会(AACOM)合作,将有利于促进儿童神经病学事业的未来研究。确定全美各机构的所有儿童神经病学助理主任和医学教育领导,
{"title":"Child Neurology Workforce Shortage: Challenges and Recommendations for Researching and Recruiting the Next Generation of Child Neurologists","authors":"Sara A. Rubin,&nbsp;Peter E. Davis,&nbsp;Miya E. Bernson-Leung","doi":"10.1002/cns3.70011","DOIUrl":"https://doi.org/10.1002/cns3.70011","url":null,"abstract":"<p>For subspecialities like child neurology in which demand is predicted to increase and further exceed supply, understanding what attracts individuals to the field and deters individuals from it is particularly valuable. To explore this, we recently surveyed medical students and residents who had completed child neurology clerkships at US medical schools within the last approximately 7 years to investigate the antecedent factors that led to interest in these clerkships and the factors that subsequently impacted residency choice, child neurology or otherwise. Current child neurology and neurodevelopmental disabilities residents (postgraduate years [PGY] 1 through 5) and current medical students who completed at least one child neurology clerkship at a US medical institution were invited to complete an online survey through their residency program coordinators/directors or clerkship coordinators/directors. While our 38 respondents gave us useful insights, our difficulty reaching a larger sample of the population of interest (likely ~1000−5000 individuals) highlights several barriers to conducting workforce research. Here, we share relevant literature and our observations on the pipeline for careers in child neurology, current research challenges, and potential paths forward.</p><p>Early exposure to child neurology is critical for sparking interest in the field. Although studies have used different definitions of “early,” frequently referring to college and medical school [<span>1</span>], it is becoming more apparent that no exposure is too early for igniting interest. In our study, the most common timeframe for initial exposure to neurology was during college at 39%; however, exposure in high school or earlier was almost equally as common (37%). Popular media such as books by Oliver Sacks and fictional characters like Sherlock Holmes have been cited in residency personal statements as motivating interest in neurology [<span>2</span>]. These exposures along with chance encounters with neurologists through personal or family experience with neurological conditions, pediatric or otherwise, appear to be relevant when medical students are planning their career paths. It remains to be explored whether the specific exposure (pediatric, e.g., a sibling with autism, or adult, e.g., a grandparent with Alzheimer's disease) influences whether one decides to go into child neurology or adult neurology, especially given the lack of awareness among premedical and medical students that child neurology is its own specialty. Studying these types of “early” exposures could be fruitful for understanding how early lifeexperiences influence motivation to enter medicine and eventual specialty choice.</p><p>Undergraduate neuroscience courses are another crucial early exposure to the field. At present, there are inequities in access to such courses, which has implications for recruiting a diverse workforce [<span>3</span>]. In our survey, 24% of participants indicated tha","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"68-70"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70011","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report 芬氟拉明:尿药检假阳性的罕见原因:1例报告
Pub Date : 2025-06-10 DOI: 10.1002/cns3.70012
Maria Ghawji, Meagan Hainlen, Charuta Joshi

Background

Fenfluramine is an antiseizure medication approved by the Food and Drug Administration for the treatment of Dravet syndrome in patients older than 2 years. Fenfluramine is an amphetamine derivative. It cross-reacts with amphetamines in urine drug screen immunoassays.

Patient Presentation

A 2-year-old patient with Dravet syndrome had a cardiorespiratory arrest and tested positive for amphetamines in a urine drug screen, raising concerns of child abuse. Liquid chromatography–mass spectrometry confirmed the presence of fenfluramine but did not detect amphetamines.

Conclusion

Fenfluramine can result in a false-positive amphetamine urine drug screen at the recommended dose for Dravet syndrome. Awareness of this potential cross-reactivity can prevent undue child protective services reports, especially in patients at high risk for sudden death.

背景:芬氟拉明是一种抗癫痫药物,经美国食品和药物管理局批准用于治疗2岁以上患者的Dravet综合征。芬氟拉明是一种安非他明的衍生物。它在尿液药物筛选免疫分析中与安非他明交叉反应。一名患有德拉韦综合征的2岁患者出现了心肺骤停,并在尿液药物筛查中检测出安非他明呈阳性,这引起了人们对虐待儿童的关注。液相色谱-质谱联用证实了芬氟拉明的存在,但未检测到安非他明。结论芬氟拉明在Dravet综合征推荐剂量下可导致安非他命尿药筛查假阳性。认识到这种潜在的交叉反应可以防止儿童保护服务报告不当,特别是在猝死高风险患者中。
{"title":"Fenfluramine: An Uncommon Cause of False Positive Urine Drug Testing: A Case Report","authors":"Maria Ghawji,&nbsp;Meagan Hainlen,&nbsp;Charuta Joshi","doi":"10.1002/cns3.70012","DOIUrl":"https://doi.org/10.1002/cns3.70012","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Fenfluramine is an antiseizure medication approved by the Food and Drug Administration for the treatment of Dravet syndrome in patients older than 2 years. Fenfluramine is an amphetamine derivative. It cross-reacts with amphetamines in urine drug screen immunoassays.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patient Presentation</h3>\u0000 \u0000 <p>A 2-year-old patient with Dravet syndrome had a cardiorespiratory arrest and tested positive for amphetamines in a urine drug screen, raising concerns of child abuse. Liquid chromatography–mass spectrometry confirmed the presence of fenfluramine but did not detect amphetamines.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Fenfluramine can result in a false-positive amphetamine urine drug screen at the recommended dose for Dravet syndrome. Awareness of this potential cross-reactivity can prevent undue child protective services reports, especially in patients at high risk for sudden death.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"121-124"},"PeriodicalIF":0.0,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70012","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone 推进火灾治疗:鞘内地塞米松的潜力
Pub Date : 2025-05-11 DOI: 10.1002/cns3.70008
Carol Park, Douglas R. Nordli III, Mohamed Taha, Henry David, Shawn Kacker, Tareq Kass-Hout, Sonam Thind, Aurelie Hanin, Sana Said, Hiba A. Haider, Douglas R. Nordli Jr.

Background

Febrile infection-related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness.

Patient Description

We describe a 12-year-old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT-DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT-DEX led to rapid seizure control and significant neurological recovery.

Conclusion

This report supports IT-DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long-term efficacy.

背景发热性感染相关癫痫综合征(FIRES)是一种罕见的破坏性癫痫综合征,其特征是发热性疾病后的难治性癫痫持续状态。我们描述了一名患有FIRES的12岁女孩,在多次抗癫痫和免疫调节治疗失败后,她对鞘内地塞米松(IT-DEX)表现出显着的临床和电反应。尽管持续的神经炎症,IT-DEX导致快速控制癫痫发作和显著的神经恢复。结论本报告支持IT-DEX作为一种有前景的干预措施,并强调需要进一步研究其机制和长期疗效。
{"title":"Advancing FIRES Treatment: The Potential of Intrathecal Dexamethasone","authors":"Carol Park,&nbsp;Douglas R. Nordli III,&nbsp;Mohamed Taha,&nbsp;Henry David,&nbsp;Shawn Kacker,&nbsp;Tareq Kass-Hout,&nbsp;Sonam Thind,&nbsp;Aurelie Hanin,&nbsp;Sana Said,&nbsp;Hiba A. Haider,&nbsp;Douglas R. Nordli Jr.","doi":"10.1002/cns3.70008","DOIUrl":"https://doi.org/10.1002/cns3.70008","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Febrile infection-related epilepsy syndrome (FIRES) is a rare, devastating epilepsy syndrome characterized by refractory status epilepticus following a febrile illness.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Patient Description</h3>\u0000 \u0000 <p>We describe a 12-year-old girl with FIRES who exhibited a remarkable clinical and electrographic response to intrathecal dexamethasone (IT-DEX) after failing multiple antiseizure and immunomodulatory therapies. Despite persistent neuroinflammation, IT-DEX led to rapid seizure control and significant neurological recovery.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This report supports IT-DEX as a promising intervention in FIRES and underscores the need for further research into its mechanisms and long-term efficacy.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"115-120"},"PeriodicalIF":0.0,"publicationDate":"2025-05-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144299750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction to “Rett Syndrome: The Natural History Study Journey” 更正“Rett综合征:自然史研究之旅”
Pub Date : 2025-04-18 DOI: 10.1002/cns3.70004

Percy AK, Benke TA, Marsh ED, Neul JL. Rett syndrome: The Natural History Study Journey. Ann Child Neurol Soc. 2024;2(3):189–205. doi: 10.1002/cns3.20086.

We apologize for this error.

Percy AK, Benke TA, Marsh ED, Neul JL。雷特综合症:自然史研究之旅。中华神经科杂志,2014;2(3):189-205。doi: 10.1002 / cns3.20086。我们为这个错误道歉。
{"title":"Correction to “Rett Syndrome: The Natural History Study Journey”","authors":"","doi":"10.1002/cns3.70004","DOIUrl":"https://doi.org/10.1002/cns3.70004","url":null,"abstract":"<p>Percy AK, Benke TA, Marsh ED, Neul JL. Rett syndrome: The Natural History Study Journey. <i>Ann Child Neurol Soc</i>. 2024;2(3):189–205. doi: 10.1002/cns3.20086.</p><p>We apologize for this error.</p>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300297","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Ears of the Lynx” Sign on Brain MRI in Siblings With Spastic Paraplegia: A Case Report 兄弟姐妹痉挛性截瘫的脑MRI显示“山猫之耳”征:1例报告
Pub Date : 2025-03-25 DOI: 10.1002/cns3.20105
Qingqing Wang, Manikum Moodley

Background

Hereditary spastic paraplegia (HSP) is a rare, clinically and genetically heterogenous condition that selectively affects the terminal segment of the descending corticospinal tract of the lumbar spine area, causing lower extremity spastic weakness with or without associated complex neurological symptoms. HSP type 11 is the most common form of autosomal recessive HSP and has unique clinical and neuroimaging features.

Methods

We describe the clinical manifestations and imaging features of siblings with childhood-onset autosomal recessive HSP. Genetic testing confirmed compound heterozygous spastic paraplegia gene (SPG) 11 mutations.

Results

The older brother developed poor balance and progressive difficulty with walking starting in childhood. He also experienced poor memory and urinary incontinence. He was born preterm at 30 weeks and was developmentally delayed and cognitivly impaired. His examination revealed length-dependent corticospinal tract signs. Magnetic resonance imaging (MRI) showed thinning of the corpus callosum and periventricular signal changes. His earlier cerebral palsy (CP) diagnosis was based on the history and imaging findings, but rcognition of the “ears of the lynx” MRI sign led to the correct diagnosis of HSP 11 with the Invitae HSP gene panel. The younger sister has similar but milder manifestations and, has the same mutation as her brother.

Interpretation

Although the manifestations of HSP in children often mimic those of CP, the management and progression of HSP differ substantially.

背景:遗传性痉挛性截瘫(HSP)是一种罕见的、临床和遗传异质性的疾病,它选择性地影响腰椎区域皮质脊髓束下降末端段,导致下肢痉挛性无力,伴有或不伴有复杂的神经系统症状。11型HSP是最常见的常染色体隐性HSP,具有独特的临床和神经影像学特征。方法对兄弟姐妹儿童期常染色体隐性遗传病的临床表现和影像学特征进行分析。基因检测证实复合杂合性痉挛性截瘫基因(SPG) 11突变。结果哥哥从童年开始出现平衡能力差和进行性行走困难。他还经历了记忆力差和尿失禁。他在30周时早产,发育迟缓,认知受损。他的检查显示长度依赖的皮质脊髓束征象。磁共振成像(MRI)显示胼胝体变薄,脑室周围信号改变。他早期的脑瘫(CP)诊断是基于病史和影像学结果,但对“山猫耳”MRI征的认识导致了使用Invitae HSP基因小组正确诊断hsp11。妹妹有类似但较温和的表现,并有相同的突变,她的哥哥。虽然儿童热休克的表现通常与CP相似,但热休克的处理和进展却有很大不同。
{"title":"“Ears of the Lynx” Sign on Brain MRI in Siblings With Spastic Paraplegia: A Case Report","authors":"Qingqing Wang,&nbsp;Manikum Moodley","doi":"10.1002/cns3.20105","DOIUrl":"https://doi.org/10.1002/cns3.20105","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Hereditary spastic paraplegia (HSP) is a rare, clinically and genetically heterogenous condition that selectively affects the terminal segment of the descending corticospinal tract of the lumbar spine area, causing lower extremity spastic weakness with or without associated complex neurological symptoms. HSP type 11 is the most common form of autosomal recessive HSP and has unique clinical and neuroimaging features.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We describe the clinical manifestations and imaging features of siblings with childhood-onset autosomal recessive HSP. Genetic testing confirmed compound heterozygous spastic paraplegia gene (SPG) 11 mutations.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The older brother developed poor balance and progressive difficulty with walking starting in childhood. He also experienced poor memory and urinary incontinence. He was born preterm at 30 weeks and was developmentally delayed and cognitivly impaired. His examination revealed length-dependent corticospinal tract signs. Magnetic resonance imaging (MRI) showed thinning of the corpus callosum and periventricular signal changes. His earlier cerebral palsy (CP) diagnosis was based on the history and imaging findings, but rcognition of the “ears of the lynx” MRI sign led to the correct diagnosis of HSP 11 with the Invitae HSP gene panel. The younger sister has similar but milder manifestations and, has the same mutation as her brother.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interpretation</h3>\u0000 \u0000 <p>Although the manifestations of HSP in children often mimic those of CP, the management and progression of HSP differ substantially.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"105-109"},"PeriodicalIF":0.0,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.20105","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synergy in Child Neurology: Science, Collaboration, and Leadership – The 2024 Hower Award Lecture 儿童神经病学的协同作用:科学、合作和领导——2024年胡佛奖演讲
Pub Date : 2025-03-19 DOI: 10.1002/cns3.70005
Renée A. Shellhaas
<p>This is an exciting era in child neurology! The scientific state of the art is accelerating rapidly. New diagnostics and treatments are here – or are coming quickly. And our community of researchers, clinicians, and educators is becoming more diverse and increasingly representative of the children and families we serve.</p><p>Of course, we have our challenges. What does it take to be a successful researcher in the current climate? How do we best take care of the many patients who need us? How do we recruit new colleagues and retain them in the field? Who will be the next wave of child neurology leaders? None of these questions have easy answers, but the solutions come down to three fundamental values: great science, effective and consistent collaboration, and excellent leadership.</p><p>Since the state of the art is advancing so quickly, this is a crucial time to mindfully evaluate how the new data can be incorporated into clinical practice. Apart from our need for rigorous training in implementation science and quality improvement methodology, one of our field's main challenges is the limited number of clinicians available to care for children with neurologic disease.</p><p>In 2024, 177 medical students matched into US child neurology residency programs [<span>47</span>]. We do not currently have a systematic approach to quantifying the number of nurse practitioners or physician assistants in child neurology (personal communication, Mona Jacobson, president, ACNN), but such advanced practice providers are clearly a key element of expanded access to clinical care. To enable continued advances in the state of the art, it is crucial that every single one of these individuals succeeds and is retained in child neurology. And we need to recruit far more.</p><p>Early exposure to child neurology is an essential long-term strategy. From effective pipeline programs for school-aged children, to exposure to neurosciences in the undergraduate years, and learning from outstanding and inspirational clinicians in the early months of medical and nursing school, educators matter.</p><p>It is clear that we need to develop excellent leaders in child neurology. There are countless open positions for division chiefs, section heads, and program leaders – not to mention department chairs in Pediatrics and Neurology. The <i>CNS</i> now has a committee on Leadership, Diversity, Equity, and Inclusion. This team is working to develop appropriate programming, but it is clear that support for emerging leaders must come from a range of sources – from national organizations to medical school offices of faculty development, to individuals who are willing to advise, mentor, and sponsor.</p><p>For senior child neurologists, this is a critical time to actively identify and develop emerging leaders. Challenging high-performers so they are constantly learning and performing at their highest potential is key for retention and career satisfaction – with benefit to the entire field
这是儿童神经病学的一个激动人心的时代!科学技术的发展正在迅速加速。新的诊断和治疗方法就在这里,或者很快就会出现。我们的研究人员、临床医生和教育工作者正变得越来越多样化,越来越能代表我们所服务的儿童和家庭。当然,我们也面临挑战。在当前的环境下,怎样才能成为一名成功的研究人员?我们怎样才能最好地照顾那些需要我们的病人?我们如何招募新同事并留住他们?谁将成为下一波儿童神经病学的领军人物?这些问题都没有简单的答案,但解决方案可以归结为三个基本价值观:伟大的科学,有效和持续的合作,以及卓越的领导。由于技术进步如此之快,现在是认真评估如何将新数据纳入临床实践的关键时刻。除了我们需要在实施科学和质量改进方法方面进行严格的培训外,我们领域的主要挑战之一是可用于照顾患有神经系统疾病的儿童的临床医生数量有限。在2024年,177名医学生匹配到美国儿童神经病学住院医师项目b[47]。我们目前还没有一个系统的方法来量化儿童神经病学执业护士或医师助理的数量(个人沟通,Mona Jacobson, ACNN总裁),但这些高级实践提供者显然是扩大临床护理的关键因素。为了使这项技术不断进步,至关重要的是,这些人中的每一个人都能成功,并在儿童神经病学领域得到保留。我们需要招募更多的人。早期接触儿童神经学是一项必要的长期战略。从针对学龄儿童的有效管道项目,到在本科阶段接触神经科学,以及在医学和护理学校的最初几个月向杰出和鼓舞人心的临床医生学习,教育工作者很重要。很明显,我们需要在儿童神经学方面培养优秀的领导者。有无数的部门主管、部门主管和项目负责人的空缺职位,更不用说儿科和神经病学的系主任了。CNS现在有一个关于领导力、多样性、公平性和包容性的委员会。这个团队正在努力制定适当的计划,但很明显,对新兴领导者的支持必须来自一系列来源——从国家组织到医学院教员发展办公室,再到愿意提供建议、指导和赞助的个人。对于资深儿童神经学家来说,这是积极识别和培养新兴领导者的关键时期。挑战优秀员工,让他们不断学习并发挥最大潜力,这是留住员工和提高职业满意度的关键——这对整个行业和我们所服务的孩子都有好处。对于新兴的领导者,请充分利用导师和赞助商提供的机会。我鼓励你们利用当地的职业发展资源,以及通过CNS和其他专业组织提供的领导力发展机会。拓展你的职业关系网——让你的同事、导师和潜在的赞助人知道你的职业抱负。大胆地实现你的愿景,并愿意为实现这一愿景而投入耐心、渐进的日常工作。rensame A. Shellhaas:概念化,调查,写作-原稿,方法论,可视化,写作-审查和编辑,资源。RAS作为儿科癫痫研究基金会主席获得津贴,作为癫痫研究联盟的顾问,并从UpToDate获得与新生儿癫痫发作相关主题的作者版税。作为医生的执行教练,她获得报酬。她还担任ACNS编辑委员会成员。
{"title":"Synergy in Child Neurology: Science, Collaboration, and Leadership – The 2024 Hower Award Lecture","authors":"Renée A. Shellhaas","doi":"10.1002/cns3.70005","DOIUrl":"https://doi.org/10.1002/cns3.70005","url":null,"abstract":"&lt;p&gt;This is an exciting era in child neurology! The scientific state of the art is accelerating rapidly. New diagnostics and treatments are here – or are coming quickly. And our community of researchers, clinicians, and educators is becoming more diverse and increasingly representative of the children and families we serve.&lt;/p&gt;&lt;p&gt;Of course, we have our challenges. What does it take to be a successful researcher in the current climate? How do we best take care of the many patients who need us? How do we recruit new colleagues and retain them in the field? Who will be the next wave of child neurology leaders? None of these questions have easy answers, but the solutions come down to three fundamental values: great science, effective and consistent collaboration, and excellent leadership.&lt;/p&gt;&lt;p&gt;Since the state of the art is advancing so quickly, this is a crucial time to mindfully evaluate how the new data can be incorporated into clinical practice. Apart from our need for rigorous training in implementation science and quality improvement methodology, one of our field's main challenges is the limited number of clinicians available to care for children with neurologic disease.&lt;/p&gt;&lt;p&gt;In 2024, 177 medical students matched into US child neurology residency programs [&lt;span&gt;47&lt;/span&gt;]. We do not currently have a systematic approach to quantifying the number of nurse practitioners or physician assistants in child neurology (personal communication, Mona Jacobson, president, ACNN), but such advanced practice providers are clearly a key element of expanded access to clinical care. To enable continued advances in the state of the art, it is crucial that every single one of these individuals succeeds and is retained in child neurology. And we need to recruit far more.&lt;/p&gt;&lt;p&gt;Early exposure to child neurology is an essential long-term strategy. From effective pipeline programs for school-aged children, to exposure to neurosciences in the undergraduate years, and learning from outstanding and inspirational clinicians in the early months of medical and nursing school, educators matter.&lt;/p&gt;&lt;p&gt;It is clear that we need to develop excellent leaders in child neurology. There are countless open positions for division chiefs, section heads, and program leaders – not to mention department chairs in Pediatrics and Neurology. The &lt;i&gt;CNS&lt;/i&gt; now has a committee on Leadership, Diversity, Equity, and Inclusion. This team is working to develop appropriate programming, but it is clear that support for emerging leaders must come from a range of sources – from national organizations to medical school offices of faculty development, to individuals who are willing to advise, mentor, and sponsor.&lt;/p&gt;&lt;p&gt;For senior child neurologists, this is a critical time to actively identify and develop emerging leaders. Challenging high-performers so they are constantly learning and performing at their highest potential is key for retention and career satisfaction – with benefit to the entire field ","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"71-77"},"PeriodicalIF":0.0,"publicationDate":"2025-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.70005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300410","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Deep Phenotyping of the Broader Autism Phenotype in Epilepsy: A Transdiagnostic Marker of Epilepsy and Autism Spectrum Disorder 癫痫中更广泛的自闭症表型的深度表型:癫痫和自闭症谱系障碍的跨诊断标记
Pub Date : 2025-03-18 DOI: 10.1002/cns3.20104
Annie E. Richard, Ingrid E. Scheffer, Sarah J. Wilson

Objective

We conducted deep and minimal phenotyping of the broader autism phenotype (BAP) in people with epilepsy (PWE) and compared its expression with published rates in the general population and relatives of individuals with autism spectrum disorder (ASD-relatives). We then examined the association of clinical epilepsy variables with BAP expression to explore its underpinnings in PWE.

Methods

103 adults with seizures (Mage = 37.37, SD = 12.50; 47% males; 51 temporal lobe epilepsy, 40 genetic generalized epilepsy, 12 other) and 58 community members (Mage = 39.59, SD = 14.56; 35% males) underwent deep phenotyping using the observer-rated Autism Endophenotype Interview and minimal phenotyping with the Broader Autism Phenotype Questionnaire (BAPQ). Published rates of the BAP were ascertained from large randomly selected samples (n > 100) of the general population and ASD-relatives based on BAPQ data.

Results

There was a higher rate of BAP in PWE (15% males, 27% females) compared with the general population (5% males, 7% females) and a similar rate to ASD-relatives (9% males, 20% females). Deep phenotyping identified an additional 22 males and 10 females, with the combined measures indicating elevated rates of the BAP in PWE (44% males, 36% females). Only a shorter duration of epilepsy was weakly correlated with BAP trait expression in males (r = − 0.21, p = 0.05).

Interpretation

PWE have a high rate of BAP, largely unrelated to secondary clinical epilepsy effects. The BAP may provide a trans-diagnostic marker of shared etiological mechanisms of epilepsy and ASD and partly account for psychosocial difficulties faced by PWE with childhood or adult onset of seizures.

我们对癫痫患者(PWE)的广义自闭症表型(BAP)进行了深度和最小表型分析,并将其表达率与已公布的一般人群和自闭症谱系障碍患者亲属(ASD-relatives)的表达率进行了比较。然后,我们检查了临床癫痫变量与BAP表达的关联,以探索其在PWE中的基础。方法103例成人癫痫发作患者(Mage = 37.37, SD = 12.50;男性47%;51例颞叶癫痫,40例遗传性广泛性癫痫,12例其他)和58例社区成员(Mage = 39.59, SD = 14.56;(35%男性)使用观察者评价的自闭症内表型访谈进行深度表型分型,并使用广义自闭症表型问卷(BAPQ)进行最小表型分型。公布的BAP发生率是根据BAPQ数据从普通人群和asd亲属中随机抽取的大量样本(n > 100)中确定的。结果PWE患者的BAP发生率(男性15%,女性27%)高于普通人群(男性5%,女性7%),与asd亲属(男性9%,女性20%)相似。深度表型鉴定了另外22名男性和10名女性,综合测量表明PWE中BAP的发生率升高(男性44%,女性36%)。男性癫痫持续时间越短,与BAP性状表达呈弱相关(r = - 0.21, p = 0.05)。PWE患者BAP发生率高,与继发性癫痫临床效应无关。BAP可能提供癫痫和ASD共同病因机制的跨诊断标记,并部分解释儿童期或成年期癫痫发作的PWE所面临的社会心理困难。
{"title":"Deep Phenotyping of the Broader Autism Phenotype in Epilepsy: A Transdiagnostic Marker of Epilepsy and Autism Spectrum Disorder","authors":"Annie E. Richard,&nbsp;Ingrid E. Scheffer,&nbsp;Sarah J. Wilson","doi":"10.1002/cns3.20104","DOIUrl":"https://doi.org/10.1002/cns3.20104","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>We conducted deep and minimal phenotyping of the broader autism phenotype (BAP) in people with epilepsy (PWE) and compared its expression with published rates in the general population and relatives of individuals with autism spectrum disorder (ASD-relatives). We then examined the association of clinical epilepsy variables with BAP expression to explore its underpinnings in PWE.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>103 adults with seizures (<i>M</i><sub>age</sub> = 37.37, SD = 12.50; 47% males; 51 temporal lobe epilepsy, 40 genetic generalized epilepsy, 12 other) and 58 community members (<i>M</i><sub>age</sub> = 39.59, SD = 14.56; 35% males) underwent deep phenotyping using the observer-rated Autism Endophenotype Interview and minimal phenotyping with the Broader Autism Phenotype Questionnaire (BAPQ). Published rates of the BAP were ascertained from large randomly selected samples (<i>n</i> &gt; 100) of the general population and ASD-relatives based on BAPQ data.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>There was a higher rate of BAP in PWE (15% males, 27% females) compared with the general population (5% males, 7% females) and a similar rate to ASD-relatives (9% males, 20% females). Deep phenotyping identified an additional 22 males and 10 females, with the combined measures indicating elevated rates of the BAP in PWE (44% males, 36% females). Only a shorter duration of epilepsy was weakly correlated with BAP trait expression in males (<i>r</i> = − 0.21, <i>p</i> = 0.05).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Interpretation</h3>\u0000 \u0000 <p>PWE have a high rate of BAP, largely unrelated to secondary clinical epilepsy effects. The BAP may provide a trans-diagnostic marker of shared etiological mechanisms of epilepsy and ASD and partly account for psychosocial difficulties faced by PWE with childhood or adult onset of seizures.</p>\u0000 </section>\u0000 </div>","PeriodicalId":72232,"journal":{"name":"Annals of the Child Neurology Society","volume":"3 2","pages":"78-90"},"PeriodicalIF":0.0,"publicationDate":"2025-03-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cns3.20104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144300198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Annals of the Child Neurology Society
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1